CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.670
-0.050 (-1.34%)
At close: Jul 19, 2024, 4:00 PM
3.630
-0.040 (-1.09%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $823.20 million as of July 22, 2024. Its market cap has decreased by -62.01% in one year.
Market Cap
823.20M
Enterprise Value
536.39M
1-Year Change
-62.01%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $2.82B to $823.20M, a decrease of -70.84%. That is a compound annual growth rate of -26.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 823.20M | -12.68% |
Dec 29, 2023 | 942.70M | -17.84% |
Dec 30, 2022 | 1.15B | -82.12% |
Dec 31, 2021 | 6.42B | -55.14% |
Dec 31, 2020 | 14.31B | 406.69% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Healthcare Services Group | 846.20M |
GeneDx Holdings | 832.38M |
InnovAge Holding | 825.45M |
Mesoblast | 825.11M |
Cogent Biosciences | 823.23M |
89bio | 821.51M |
The Pennant Group | 815.44M |
Standard BioTools | 811.22M |